We are live on ! Find out more
NFA

Nationwide Fund Advisors Portfolio holdings

AUM $2.42B
1-Year Est. Return 17.68%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+17.68%
3 Year Est. Return
+28.25%
5 Year Est. Return
+4.07%
10 Year Est. Return
+82.68%
AUM
$23.9B
AUM Growth
+$802M
Cap. Flow
-$183M
Cap. Flow %
-0.77%
Top 10 Hldgs %
10.35%
Holding
3,340
New
74
Increased
975
Reduced
1,112
Closed
111

Top Buys

Rank Stock Value
1
CAG icon
Conagra Brands
CAG
+$29.6M
2
WM icon
Waste Management
WM
+$28.1M
3
AMZN icon
Amazon
AMZN
+$28.1M
4
JNJ icon
Johnson & Johnson
JNJ
+$24.7M
5
ABBV icon
AbbVie
ABBV
+$24M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$30.1M
2
EMC
EMC CORPORATION
EMC
+$28.3M
3
NKE icon
Nike
NKE
+$24.2M
4
RTN
Raytheon Company
RTN
+$24.1M
5
BMY icon
Bristol-Myers Squibb
BMY
+$22.4M

Sector Composition

Rank Sector Weight
1 Technology 15.97%
2 Healthcare 14.22%
3 Financials 13.72%
4 Industrials 11.98%
5 Consumer Discretionary 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRTX
3051
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$48K ﹤0.01%
7,245
– –
UFAB
3052
DELISTED
Unique Fabricating, Inc.
UFAB
$48K ﹤0.01%
3,922
– –
INFI
3053
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$48K ﹤0.01%
31,080
– –
SKUL
3054
DELISTED
SKULLCANDY INC
SKUL
$48K ﹤0.01%
7,551
-5,188
-41% -$32.3K
FBRC
3055
DELISTED
FBR & Co. Common Stock
FBRC
$48K ﹤0.01%
3,620
-10,072
-74% -$145K
FLNT
3056
Fluent
FLNT
$104M
$47K ﹤0.01%
1,550
– –
LPCN icon
3057
Lipocine
LPCN
$17.1M
$47K ﹤0.01%
619
– –
TAX
3058
DELISTED
Liberty Tax, Inc. Class A
TAX
$47K ﹤0.01%
3,688
– –
TPB icon
3059
Turning Point Brands
TPB
$1.52B
$45K ﹤0.01%
3,709
– –
VSLR
3060
DELISTED
VIVINT SOLAR, INC.
VSLR
$45K ﹤0.01%
14,165
– –
PTGX icon
3061
Protagonist Therapeutics
PTGX
$8.66B
$44K ﹤0.01%
+2,101
New +$28.7K
ARGS
3062
DELISTED
Argos Therapeutics, Inc.
ARGS
$44K ﹤0.01%
439
+107
+32% +$11.2K
KOS icon
3063
Kosmos Energy
KOS
$1.53B
$43K ﹤0.01%
6,650
+4,072
+158% +$23.8K
SNDX icon
3064
Syndax Pharmaceuticals
SNDX
$1.7B
$43K ﹤0.01%
2,850
– –
AVGR
3065
DELISTED
Avinger, Inc. Common Stock
AVGR
– –
0
– –
KIN
3066
DELISTED
Kindred Biosciences, Inc.
KIN
$43K ﹤0.01%
8,600
– –
ABCD
3067
DELISTED
Cambium Learning Group, Inc.
ABCD
$43K ﹤0.01%
7,885
– –
STRL icon
3068
Sterling Infrastructure
STRL
$18.6B
$42K ﹤0.01%
5,417
– –
SPNE
3069
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$42K ﹤0.01%
4,172
-200
-5% -$2.07K
HOME
3070
DELISTED
At Home Group Inc.
HOME
$42K ﹤0.01%
+2,800
New +$41K
GSOL
3071
DELISTED
Global Sources Ltd
GSOL
$42K ﹤0.01%
4,913
– –
NYNY
3072
DELISTED
Empire Resorts, Inc.
NYNY
$42K ﹤0.01%
2,093
– –
RXII
3073
DELISTED
GALENA BIOPHARMA INC COM
RXII
$42K ﹤0.01%
119,722
– –
AST
3074
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$42K ﹤0.01%
10,005
– –
PVBC
3075
DELISTED
Provident Bancorp
PVBC
$40K ﹤0.01%
5,139
– –
121 122
123
124 125

Similar funds

BBA
BLB&B Advisors Montgomeryville, Pennsylvania $2.42B AUM 22.12% 1-Year Est. Return
PUI
Purpose Unlimited Inc Toronto $2.42B AUM
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
PA
Paralel Advisors Denver, Colorado $2.41B AUM 9.57% 1-Year Est. Return
KFA
Krane Funds Advisors New York $2.44B AUM 12.99% 1-Year Est. Return
TMC
Toyota Motor Corp Japan $2.44B AUM 10.97% 1-Year Est. Return
QT
Quantbot Technologies New York $2.44B AUM 17.13% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Nationwide Fund Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Nationwide Fund Advisors held 3,340 positions worth $23.9B, up 3.5% from $23.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Nationwide Fund Advisors's Q3 2016 filing shows 74 new, 975 increased, 1,112 reduced and 111 closed positions. Its largest new stake was GSK: 285,626 shares worth $15.4M. The largest sale was Broadcom, an estimated $30.1M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • Nationwide Fund Advisors's largest Q3 2016 buy was GSK: 285,626 shares worth $15.4M.
  • Nationwide Fund Advisors added most to Conagra Brands in Q3 2016, an estimated $29.6M increase.
  • Nationwide Fund Advisors's biggest Q3 2016 reduction was Broadcom, cutting an estimated $30.1M.
  • Nationwide Fund Advisors fully exited EMC CORPORATION in Q3 2016, selling an estimated $28.3M.
  • Nationwide Fund Advisors's ten largest holdings make up 10% of its $23.9B portfolio in Q3 2016.
  • Nationwide Fund Advisors opened 74 new positions and closed 111 in Q3 2016.
  • Nationwide Fund Advisors's portfolio value rose 3.5% quarter-over-quarter to $23.9B.

Based on Nationwide Fund Advisors's 13F filing for Q3 2016, filed 20 Oct 2016.